Health Wire East Timor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire East Timor.

Press releases published on March 17, 2026

Mar. 17, 2026

Hyperion DeFi Schedules Fourth Quarter and Full Year 2025 Earnings Call for Thursday, March 26 at 8:00 a.m. ET

Indeterminate GlobeNewswire

Mar. 17, 2026

Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

Indeterminate GlobeNewswire

Mar. 17, 2026

Axe Compute Appoints Two Technology and Telecom Luminaries to Board of Directors as Company Accelerates AI Infrastructure Strategy

Indeterminate GlobeNewswire

Mar. 17, 2026

Microbot Medical® to Participate at the 38th Annual Roth Conference

Indeterminate GlobeNewswire

Mar. 17, 2026

ReFocus Eye Health Expands Presence Through Strategic Affiliation with Seven Partner Practices and Four Ambulatory Surgery Centers

Indeterminate GlobeNewswire

Mar. 17, 2026

Quantum Cyber Aligns Strategy With Trump Administration's National Cyber Security Framework, Targets Acquisitions in Quantum and Cyber Defense Sectors

Indeterminate GlobeNewswire

Mar. 17, 2026

Empassion Health and Karoo Health Partner to Support Patients with Advanced Heart Disease and Other Serious Illness

Indeterminate GlobeNewswire

Mar. 17, 2026

ORAGENICS FILES ANNUAL REPORT ON FORM 10-K

Indeterminate GlobeNewswire

Mar. 17, 2026

Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

Indeterminate GlobeNewswire

Mar. 17, 2026

Sofwave Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Achieves Full-Year Profitability

Indeterminate GlobeNewswire

Mar. 17, 2026

Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth

Indeterminate GlobeNewswire

Mar. 17, 2026

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Indeterminate GlobeNewswire

Mar. 17, 2026

PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application

Indeterminate GlobeNewswire

Mar. 17, 2026

New InsiGHTS Trial of TransCon® hGH (Lonapegsomatropin) in Turner Syndrome Demonstrated Comparable Efficacy and Safety to Daily Somatropin at Week 52

Indeterminate GlobeNewswire

Mar. 17, 2026

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease

Indeterminate GlobeNewswire

Mar. 17, 2026

Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program

Indeterminate GlobeNewswire

Mar. 17, 2026

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Indeterminate GlobeNewswire

Mar. 17, 2026

Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families

Indeterminate GlobeNewswire

Mar. 17, 2026

Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors

Indeterminate GlobeNewswire

Mar. 17, 2026

Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions

Indeterminate GlobeNewswire